A decision tree for differentiating tuberculous from malignant pleural effusions
- PMID: 18573650
- DOI: 10.1016/j.rmed.2008.03.001
A decision tree for differentiating tuberculous from malignant pleural effusions
Abstract
Objective: To improve physicians' ability to discriminate tuberculous from malignant pleural effusions through a simple clinical algorithm that avoids pleural biopsy.
Design: We retrospectively compared the clinical and pleural fluid features of 238 adults with pleural effusion who satisfied diagnostic criteria for tuberculosis (n=64) or malignancy (n=174) at one academic center (derivation cohort). Then, we built a decision tree model to predict tuberculosis using the C4.5 algorithm. The model was validated with an independent sample set from another center that included 74 tuberculous and 293 malignant effusions (validation cohort).
Results: Among 12 potential predictor variables, the classification tree analysis selected four discriminant parameters (age>35 years, pleural fluid adenosine deaminase>38U/L, temperature>or=37.8 degrees C, and pleural fluid LDH>320U/L) from the derivation cohort. The generated flowchart had 92.2% sensitivity, 98.3% specificity, and an area under the ROC curve of 0.976 for diagnosing tuberculosis. The corresponding operating characteristics for the validation cohort were 85.1%, 96.9% and 0.958.
Conclusions: Applying a decision tree analysis that contains simple clinical and laboratory data can help in the differential diagnosis of tuberculous and malignant pleural effusions.
Similar articles
-
Differentiating tuberculous from malignant pleural effusions: a scoring model.Med Sci Monit. 2003 May;9(5):CR175-80. Med Sci Monit. 2003. PMID: 12761453
-
[Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jul;27(7):435-8. Zhonghua Jie He He Hu Xi Za Zhi. 2004. PMID: 15312552 Chinese.
-
Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy.J Physiol Pharmacol. 2008 Dec;59 Suppl 6:349-60. J Physiol Pharmacol. 2008. PMID: 19218659
-
Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.QJM. 2007 Jun;100(6):351-9. doi: 10.1093/qjmed/hcm032. QJM. 2007. PMID: 17525131 Review.
-
[Diagnosis and treatment of tuberculous pleurisy--with special reference to the significance of measurement of pleural fluid cytokines].Kekkaku. 2004 Apr;79(4):289-95. Kekkaku. 2004. PMID: 15168435 Review. Japanese.
Cited by
-
Diagnostic tests for tuberculous pleural effusion.Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1187-93. doi: 10.1007/s10096-010-0986-z. Epub 2010 Jun 16. Eur J Clin Microbiol Infect Dis. 2010. PMID: 20556468 Review.
-
Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.Int J Gen Med. 2016 Jun 11;9:183-9. doi: 10.2147/IJGM.S100237. eCollection 2016. Int J Gen Med. 2016. PMID: 27354819 Free PMC article.
-
Tuberculosis disease diagnosis using artificial immune recognition system.Int J Med Sci. 2014 Mar 29;11(5):508-14. doi: 10.7150/ijms.8249. eCollection 2014. Int J Med Sci. 2014. PMID: 24688316 Free PMC article.
-
A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging.Eur Radiol. 2013 Jun;23(6):1459-66. doi: 10.1007/s00330-012-2759-9. Epub 2013 Jan 10. Eur Radiol. 2013. PMID: 23300042
-
Tuberculous pleural effusion.Lung. 2009 Sep-Oct;187(5):263-70. doi: 10.1007/s00408-009-9165-3. Epub 2009 Aug 13. Lung. 2009. PMID: 19672657 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous